# Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome

> **NCT07136454** · — · AVAILABLE · sponsor: **Oak Hill Bio Ltd**

## Conditions studied

- Angelman Syndrome

## Interventions

- **DRUG:** Rugonersen

## Key facts

- **NCT ID:** NCT07136454
- **Lead sponsor:** Oak Hill Bio Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07136454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07136454, "Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07136454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*